JP Morgan Chase’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,041,718	Closed	-$309M	–	7472
2022 Q3	$309M	Buy	2,041,718 +1,165,134	+133%	+$173M	0.05%	377
2022 Q2	$128M	Sell	876,584 -492,949	-36%	-$63M	0.02%	654
2022 Q1	$162M	Sell	1,369,533 -25,592	-2%	-$3.19M	0.02%	635
2021 Q4	$192M	Sell	1,395,125 -64,614	-4%	-$8.22M	0.02%	583
2021 Q3	$203M	Sell	1,459,739 -292,129	-17%	-$36.5M	0.03%	571
2021 Q2	$170M	Sell	1,751,868 -2,588	-0.1%	-$210K	0.02%	658
2021 Q1	$120M	Buy	1,754,456 +78,494	+5%	+$6.35M	0.02%	765
2020 Q4	$144M	Buy	1,675,962 +14,551	+0.9%	+$1.23M	0.02%	642
2020 Q3	$105M	Buy	1,661,411 +53,557	+3%	+$3.51M	0.02%	678
2020 Q2	$118M	Buy	1,607,854 +72,409	+5%	+$3.85M	0.02%	602
2020 Q1	$52.3M	Buy	1,535,445 +100,852	+7%	+$4.61M	0.01%	787
2019 Q4	$78.1M	Sell	1,434,593 -99,851	-7%	-$4.94M	0.02%	763
2019 Q3	$64M	Sell	1,534,444 -12,268	-0.8%	-$518K	0.01%	833
2019 Q2	$65.8M	Sell	1,546,712 -222,901	-13%	-$12.6M	0.01%	847
2019 Q1	$91.1M	Sell	1,769,613 -126,347	-7%	-$5.46M	0.02%	683
2018 Q4	$70.1M	Buy	1,895,960 +363,599	+24%	+$13.1M	0.02%	752
2018 Q3	$57.5M	Buy	1,532,361 +105,913	+7%	+$3.9M	0.01%	945
2018 Q2	$56.4M	Buy	1,426,448 +509,105	+55%	+$16.2M	0.01%	902
2018 Q1	$23.6M	Sell	917,343 -1,937	-0.2%	-$57.9K	0.01%	1389
2017 Q4	$24.8M	Buy	919,280 +441,027	+92%	+$12.1M	0.01%	1419
2017 Q3	$18.2M	Sell	478,253 -114,972	-19%	-$3.49M	﹤0.01%	1570
2017 Q2	$14.8M	Buy	+593,225	New	+$13.7M	﹤0.01%	1664

Other funds holding BHVN